Robenacoxib

CAS No. 220991-32-2

Robenacoxib ( —— )

Catalog No. M13524 CAS No. 220991-32-2

Robenacoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 745 Get Quote
10MG 1017 Get Quote
25MG 1431 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
500MG 4410 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Robenacoxib
  • Note
    Research use only, not for human use.
  • Brief Description
    Robenacoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs.
  • Description
    Robenacoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs, a Cyclooxygenase(COX)-1 and COX-2 inhibitor.
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    220991-32-2
  • Formula Weight
    327.28
  • Molecular Formula
    C16H13F4NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC1=CC(=C(C=C1)NC2=C(C(=CC(=C2F)F)F)F)CC(=O)O
  • Chemical Name
    {5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pelligand L, et al. BMC Vet Res. 2015 Dec 3;11:296.
2. Speranza C, et al. BMC Vet Res. 2015 Mar 26;11:79.
3. Tamura J, et al. J Vet Med Sci. 2014 Jan;76(1):113-7.
molnova catalog
related products
  • CAY10404

    CAY10404 is a potent and highly selective inhibitor of COX-2 and COX-1. It is also a potent inhibitor of PKB/Akt and MAPK signalling pathways and induces apoptosis in NSCLC cells, with analgesic, anti-inflammatory and anti-cancer activities.

  • PTUPB

    PTUPB is a novel dual acting COX-2/sEH inhibitor with IC50 of 1.26 uM/0.9 nM.

  • Naproxen

    Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.